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Abstract
Intrahost simian immunodeficiency virus (SIV) evolution is marked
by repeated viral escape from cytotoxic T-lymphocyte (CTLs) response.
Typically, the first such CTL escape occurs in a matter of days, starting
around the time of peak viral load. Many authors have developed methods
to quantify the strength of CTL response by measuring the rate at which
CTL escape occurs, but such methods usually depend on sampling at two
or more timepoints, while many datasets capture the dynamics of the first
CTL escape at only a single timepoint. Here, we develop inference meth-
ods for CTL escape rates applicable to single timepoint datasets. Through
a model of early infection dynamics, we construct confidence intervals for
escape rates, but since early infection dynamics are not completely under-
stood, we also develop a one-sided confidence interval serving as a lower
bound for escape rates over a collection of early infection models. We
apply our methods to two SIV datasets, using our lower bounds and ex-
isting methods to show that escape rates are relatively high during the
initial days of the first CTL escape and then drop to lower levels as the
escape proceeds. We also compare escape in the lymph nodes and the
rectal mucosa, showing that escape in the lymph nodes is initially faster,
but as the first escape proceeds, the rate of escape in the lymph nodes
drops below the rate seen in the rectal mucosa.
1 Introduction
During HIV and SIV infections, the viral population repeatedly escapes
from selective pressure exerted by cytotoxic T-lymphocytes (CTLs), a
type of immune system cell. Each CTL targets a specific peptide, referred
to as an epitope, associated with a locus on the viral genome. Mutation
at the locus may change the epitope, making it partially or completely
unrecognizable by existing CTLs. Cells infected by a viral genome pos-
sessing such mutations are at a selective advantage, leading to a selective
sweep referred to as a CTL escape. See [16] for a review of CTL escape
in both HIV and SIV infection.
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In this work, we consider the first CTL escape to occur during an
infection. In SIV and HIV infection, CTL response initiates roughly at
14 and 21 days after infection, respectively, just prior to peak viral load
[8, 10, 16, 26]. In the week or two following the initiation of CTL response,
CTL escape often occurs at a single targeted epitope [9, 26, 15, 17, 1]. T-
cell tetramer studies suggest that this escape is driven by an especially
focused CTL response in comparison to subsequent responses and escapes
[35, 38, 37].
Many authors have attempted to quantify the strength of CTL re-
sponse by measuring the rate at which CTL escape occurs. A commonly
used method (e.g. [15, 23, 22, 4, 14]), introduced in [11, 3], fits escape
mutation frequencies at two timepoints to a differential equation model.
The model fit is determined by a single parameter, known as the escape
rate, which is used to quantify the strength of CTL response at a given
epitope. Since this approach requires frequency data at two timepoints,
we call it the two-point method.
Using the two-point method to analyze the first CTL escape is difficult
because rarely do both sampled timepoints capture the escape. For ex-
ample, the first two timepoints available in HIV studies of acute infection
are typically in the range of day 30 and 50, e.g. [12, 15]. Using the two-
point method on such data estimates escape rates between day 30 and
50, while CTL response is likely strongest prior to day 30. The situation
is different for SIV studies. Since the time of infection can be controlled,
sampling timepoints can be chosen that straddle day 14, the approximate
time of CTL response; for example sampling can occur at days 7 and 21.
But usually the CTL escape has not started at day 7, so the two-point
method must be applied using data collected at day 21 and a later time-
point, leading to the same difficulties seen in HIV datasets. Even when
the first escape is caught twice, say at days 14 and 18, the escape rate
prior to day 14 cannot be inferred using the two-point method. Further,
when sampling times become too close, the effect of sampling variance
leads to wide confidence intervals in the two-point method.
Other authors (e.g. [24, 2, 33, 27]) have developed methods based on
the standard model of viral dynamics [32, 29]. These methods depend
on models with many parameters, in contrast the two-point method has
no parameters besides the estimated escape rate. Further, fitting of the
standard model and its variants requires multiple timepoints, so that the
time period to which such escape rate estimates apply is often unclear.
The uniqueness of the first CTL escape, in terms of its temporal as-
sociation with peak viral load and the focused CTL response that drives
it, makes its quantification biologically valuable. But further, the first
escape is free of complexitites that make later CTL escapes difficult to
model. Soon after peak viral load, in both HIV and SIV, multiple CTL
escapes occur, often overlapping in time (e.g. [6, 17, 15], see [9] for a
review). The interaction of viral variants involved in such sweeps, both
through inter-variant competition for target cells and possible recombina-
tion events, makes modeling and inference complex [19, 28, 18, 5]. From
this view, the first CTL escape may be an ideal setting in which to infer
escape rates.
The rate of CTL escape can be defined in different ways. For example,
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some authors measure the timespan from initiation of CTL response to
the time when mutant frequencies reach a prescribed level [21, 31]. In the
two-point method, using the underlying model, the escape rate is the sum
of the average CTL kill rate and the fitness cost of mutation [3, 11]. We
take this as our definition of the escape rate.
In this work, we develop inference methods for estimating the rate
of the first CTL escape using frequency data from a single timepoint.
We apply these methods to SIV datasets, a setting in which inference is
slightly easier because infection time is typically known. We have in mind
frequency data collected somewhere between days 14 and 28, times that
capture the first CTL escape when the mutation frequency is substantial,
but before escape at other epitopes has developed.
The price we pay for using a single timepoint is the addition of three
parameters: µ, the rate at which mutations accumulate in the epitope;
tA, the time at which CTL response initiates; and PA, the number of cells
infected at time tA. We build two confidence intervals (CIs) for the escape
rate. First, we build a model-based CI, making assumptions about the
infected cell growth rate and the time dependence of the CTL response.
The aim of the model-based CI is to estimate the escape rate using our
best guess of early SIV and CTL dynamics. Second, we build a lower-
bound CI. This is a one-sided CI of the form [elower,∞) that serves as a
lower bound for the escape rate. In this setting we do not choose a model
for SIV and CTL dynamics, rather we construct a CI that applies across
a range of possible models.
The early dynamics of SIV infection are not completely understood, for
instance the number of infected cells during the eclipse phase is unknown.
To deal with this uncertainty, we specify a range of possible models, and
the lower-bound CI contains the CI of all models in this range. In many
cases, as we show below, the lower-bound CI is uninformative; for example
when it contains all escape rates greater than zero. But often the lower-
bound CI is informative, allowing us to make inferences that are relatively
free of model dependence.
We apply our methods to two SIV datasets: Bimber et. al. [7] and
Vanderford et. al. [36]. For Bimber et. al., we use our methods, applied to
day 21 data, and the two-point method, applied to day 21 and 28 data, to
show the escape rate prior to day 21 is greater than the rate during days 21
to 28. Vanderford et. al. includes mutation frequency data from several
compartments, in particular lymph nodes and the rectal mucosa. As we
did for Bimber et. al, we consider two timepoints, in this case days 14
and 28, applying our method to day 14 data and the two-point method to
day 14 and 28 data. We are able to compare escape rates across different
times and compartments, showing that escape in the lymph nodes prior
to day 14 is higher than during days 14 to 28, while the escape rate in the
rectal mucosa is less than pre-day 14 rates but greater than post-day 14
rates in the lymph nodes.
Mathematical details relating to construction of the model-based and
lower-bound CIs are found in the Methods sections. Readers interested
only in biological implications can read the Results and Discussion sec-
tions.
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2 Results
Most existing analyses of CTL escape infer a single rate for the entire es-
cape, but by combining our methods with the existing two-point method,
rates can be estimated for two separate time periods of the escape. We
apply our CI construction to an early sampled timepoint, day 21 for Bim-
ber et. al and day 14 for Vanderford et. al., to infer the escape rate during
the early portion of the first CTL escape; then we apply the two-point
method using that same timepoint and a later timepoint, days 21 and 28
for Bimber et. al. and days 14 and 28 for Vanderford et. al, to infer
the escape rate during the latter portion of the CTL escape. Importantly,
although our methods use a single data timepoint, the escape rate esti-
mate applies to the time interval starting at tA, the time at which CTL
response begins, and ending at the data timepoint.
To build CIs, we must specify the three parameters µ, tA, PA. We set
µ = 3∗10−4, roughly 10 times the standard, per base pair, per replication
cycle, SIV mutation rate [25]. Our µ represents the rate at which the
epitope mutates, not the mutation rate of a single base pair. TAT-SL8
and NEF-RM9 are the epitopes considered below and both datasets reveal
roughly 10 different epitope mutations during escapes. Mandl et. al. [24]
used a similar mutation rate to analyze TAT-SL8 escape. tA, the initial
time of CTL response, and PA, the number of infected cells at time tA,
differ between the datasets and are specified below.
In some of the following figures, the CIs include negative escape rates.
Briefly, negative escape rates result from accounting for sampling variance.
For example, the mutation frequencies provided by the data might be .4
and .45 at two subsequent timepoints, but sampling variance allows the
true mutation frequencies from which the data was sampled to be, say, .43
and .42 at the subsequent timepoints. If the drop in mutation frequencies
over time has significant likelihood given the data, the CI would include
a negative escape rate.
2.1 Bimber et. al. dataset
The data from Bimber et. al. involves four Mauritian cynomolgus macaques
(MCMs) and four Rhesus macaques (RMs). (The full dataset included
eight RMs, we considered the four unvaccinated RMs.) We refer the
reader to the article and references therein for full details [7]. Briefly,
all animals were intrarectally infected with SIVmac239. The first CTL
escape in the MCMs was at the epitope NEF-RM9, while CTL escape
first occurred at TAT-SL8 in the RMs. Pyrosequencing of the epitopes
was performed at various timepoints. At day 14 after infection, for both
MCMs and RMs, the sampled sequences were roughly homogeneous; by
day 21, MCMs and RMs had a significant frequency of escape mutants at
NEF-RM9 and TAT-SL8, respectively. We assumed that CTL response
arose at day 14, i.e. tA = 14, reflecting tetramer data showing CTL re-
sponse arising at that time. PA, the number of infected cells at time tA,
has only a minor effect on the results. We tried values ranging from 106
to 1010 with little difference in outcome. Results shown were produced
using PA = 10
8.
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Figure 1: Escape Rates CIs for MCMs in Bimber et. al. Each subfigure rep-
resents a single animal. Within each subfigure, the left tic gives escape rate
CIs for days 14-21, with the model-based CI (the box) above the left endpoint
of the lower-bound CI (the darkened line). The right tic gives the escape rate
CI for days 21-28 as computed by the two-point method. All CIs are at 95%
significant and include sampling variance.
Figure 1 shows results for the four MCMs. In each subfigure, the left
tic gives our model-based and lower-bound CIs while the right tic gives the
two-point CI. As the figure shows, in three of the four animals, the escape
rate during days 14-21 appears to be higher; not only are the model-based
CIs greater than the two-point method CIs, but the lower-bound CIs are
greater as well. Interestingly, animal cy0165, which is the only animal with
overlapping two-point and lower-bound CIs, had a weak CD8+ response
from day 14 to 21 and a response that was increasing shortly after day 21
(see Figure 3 in Bimber et. al.).
Figure 2 shows analogous results for the four RMs. Like the MCMs,
for one RM the lower-bound CI is below the two-point CI, unfortunately
no tetramer data is available for comparison.
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Figure 2: Escape Rates CIs for RMs in Bimber et. al. See Figure 1 for details.
2.2 Vanderford et. al. dataset
The Vanderford et. al. dataset includes fifteen Rhesus macaques (RMs)
infected intravenously with SIVmac239. As in Bimber et. al., the RMs
experienced initial escape at TAT-SL8 and escape dynamics were tracked
using pyrosequencing. We refer the reader to the article and references
therein for full details [36], here we only mention those aspects of the
dataset relevant to our analysis. Escape dynamics were tracked in four
compartments : viral RNA in the plasma (PL) and genomic DNA from
peripheral blood mononuclear cells (PBMC), lymph node biopsies (LN),
and rectal mucosa biopsies (RB). Sequencing was performed at days 14
and 28 as well as other later timepoints. Using tetramer data, the fre-
quency of CD8+ T-lymphocytes specific for TAT-SL8 was estimated in
the different compartments at days 7, 14 and 28.
Vanderford et. al. show that lymph nodes and rectal mucosa are
the primary source of TAT-SL8 escape mutants, with escape mutants
often first arising in the lymph nodes. Given this result, we focused on
inferring rates of escape in the LN and RB compartments. In order to
consider only escape starting in lymph nodes, we restricted our attention
to animals in which PL, PBMC, and RB epitope frequencies were above
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90% at day 14 and for which LN escape data was available at days 14
and 28 (not all animals were sampled at all timepoints). Six RMs fulfilled
these requirements.
Tetramer data for the LN showed a weak CD8+ response at day 7 but
a strong response by day 14. Given this data, we assumed that significant
CTL killing started at day 9, meaning that we set tA = 9. Choosing tA > 9
would increase escape rate estimates, leaving our conclusions unchanged.
For RB, we assumed CTL killing started at day 14, also reflecting tetramer
data.
For RB, we set PA, the number of cells infected at time tA, equal
to 108. For LN, since day 9 significantly precedes peak viral load, we
hypothesized that in the absence of CTL response the LN would have
107 infected cells at day 14 and then interpolated the number of infected
cells at day 9 based on a constant growth rate; this led to PA of roughly
32000. Raising the PA values by factors of up to 100 had little effect on
our results.
Figure 3 gives confidence intervals for the escape rates in the six RMs.
Each subfigure corresponds to a single animal. The first and second tics
represent the escape rate in the LN during days 9-14, constructed using
our methods, and days 14-28, constructed using the two-point method,
respectively. The third tic represents the escape rate in RB during days
14-28, constructed using our methods and day 28 data; application of
the two-point method is not possible because escape in the RB has just
started at day 14.
Across all animals the model based CIs predict a significantly higher
LN escape rate during days 9-14 than escape rates inferred for days 14-28
using the two-point method. This pattern is supported by the lower-
bound CIs for the RMs represented in the top row, but the lower-bound
CIs in the bottom row are poor and provide little information.
Similarly, across all animals, the model-based CIs predict higher RB
escape rates during days 14-28 than those seen in the LN during the same
period. In this case, the lower-bound CIs for the RB escape rate are either
slightly above or below the LN escape rates, so we can conclude that RB
escape rates during days 14-28 are at least roughly the same as those
experienced in the LN during that time. Based on numerical experiments
(see below), lower-bound CIs are conservative, meaning that RB escape
rates are likely higher than LN escape rates during days 14-28.
3 Methods
Our model and inference methods distinguish between two types of in-
fected cells: wild type and mutants. Wild types contain the epitope at
which first CTL escape occurs, while mutants contain a nucleotide mu-
tation at that epitope. w(t) and m(t) represent the number of wild type
and mutant infected cells, respectively, at time t.
We construct our CIs under a model assuming wild type and mutants
have equal fitness. However, the CIs are applicable in the presence of
fitness differences, as we show in subsection 3.2.4.
To construct the lower-bound CI, we use the idea of a stochastic bound.
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Figure 3: Escape Rates CIs for Vanderford et. al. Each subfigure represents a
single animal. Tics, from left to right, represent escape rates in the lymph node
during days 9-14, lymph nodes during days 14-28, and rectal biopsies during
days 14-28. Within each subfigure, the left-most and right-most tics show the
model-based CI (the box) above the left endpoint of the lower-bound CI (the
darkened line). All CIs are at 95% significance.
For us, technically, a random variable Y is a stochastic upper bound of
X if both are defined on the same probability space Ω and for ω ∈ Ω,
X(ω) ≤ Y (ω); see, for example, [20] for more details and examples. A
simple example, to orient the unfamiliar reader, is the case of X as the
result of a die roll, defined by a uniform probability of rolling 1 through
6, and the stochastic upper bound Y taking the value, say, 4 on die rolls
1, 2, 3 and, say, 9 on die rolls 4, 5, 6. In the development below, we strive
to explain our stochastic bounds without excessive technicalities.
3.1 Model
In this subsection, we specify the model on which our inference is based.
For the model-based CI, we choose a specific parametrization of this
model, while for the lower-bound CI we specify and bound a range of
parametrizations.
The dynamics of w(t) are parametrized by the growth rate r(t), the
attack time tA, the CTL kill rate k(t), and PA, the number of infected
cells at time tA. The attack time identifies the beginning of CTL response,
which formally means that k(t) = 0 for t < tA. Wild type dynamics are
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then given by,
w(t) =
{
exp[
∫ t
0
dsr(s)] for t ≤ tA
PA exp[
∫ t
tA
ds(r(s)− k(s))] for t > tA (1)
Note that we assume w(0) = 1, although this is not essential. Further, we
have the consistency condition for r(t) and PA,
PA = exp[
∫ tA
0
dsr(s)]. (2)
The evolution of mutants is parametrized by a mutation rate µ and
an offspring distribution X(t; t0). Mutants arise from wild types at rate
µ. X(t; t0) is the number of infected cells at time t that arise from a
single infected cell that experiences an epitope mutation event at time t0.
X(t; t0) is a random variable for fixed t, t0. Assuming no fitness differences
between wild types and mutants gives the condition
E[X(t; t0)] = exp[
∫ t
t0
dsr(s)] (3)
=
(
w(t)
w(t0)
)
exp[
∫ t
t0
dsk(s)],
and notice if t < tA then E[X(t; t0)] = w(t)/w(t0).
We define m(t) by
m(t) =
∫ t
0
P (µw(s)ds)X(t; s), (4)
where P (µw(s)) is a Poisson process run at rate µw(s), meaning that a
mutation occurs during [s, s+∆s] with probability µw(s)∆s. When such a
mutation occurs, the random variable X(t; s) is sampled to determine the
number of mutant infected cells at time t that descend from this particular
mutation event. We make no assumption on the form of the offspring
distribution X(t; t0), aside from the constraint on E[X(t; t0)] mentioned
above. However, in (4) we assume each mutation event samples X(t; s)
independently.
3.2 Inference
For the sake of clarity, we first explain our inference methods assuming
wild types and mutants are equally fit. In subsection 3.2.4 we consider
the case of unequal fitness.
Let tF be the sampling time and fˆ the mutant frequency sampled.
Define f(t) as the fraction of infected cells of mutant type at time t, i.e.
f(t) = m(t)/(w(t) + m(t)), fˆ is formed by sampling a population with
frequency f(tF ). More formally, fˆ is a sample from the distribution f˜
defined by,
f˜ = Binomial(f(tF ), n), (5)
where Binomial(a, b) is a binomial distribution with success probability a
and b trials, and n is the number of viral sequences sampled at tF .
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We assume that f(tF ) is generated by our model under a specific
parametrization, meaning a choice for µ, tA, PA and r(t), k(t), X(t; t0). Let
k¯ be the average of k(t) over [tA, tF ], our goal is to construct confidence
intervals for k¯ given the data fˆ . Since we assume no fitness costs, k¯ is the
escape rate. Given the high dimensional parameter space, our approach is
to assume µ, tA and PA are given and then construct a model-based and
lower-bound CI for k¯. To construct the model-based CI we make specific
choices, described below, for r(t), k(t), and X(t; t0). The lower-bound CI
applies over a range of possible r(t), k(t) and X(t; t0) and is not associated
with a certain parameter choice.
Our CI constructions involve two steps.
1. Based on the model of subsection 3.1, we determine the distribution
of the mutant frequency at time tA.
2. Given the mutant frequency distribution at time tA and the data
at time tF , we use a generalized two-point method to estimate the
escape rate during [tA, tF ].
Since the mutant frequency at time tA is small, of order µ, the escape
during [tA, tF ] is still partly driven by mutation. Applying the two-point
method to the frequencies at times tA and tF would ignore this effect, re-
sulting in under-estimation of escape rates; so instead we use a generalized
two-point method which accounts for mutation.
We decompose f(tF ) based on the two steps mentioned above. From
(1) and (4), simple algebra gives
f(tF ) =
1
1 + z
Γ+zξ
, (6)
where
Γ =
m(tA)
w(tA)
, (7)
z = exp[−k¯(tF − tA)], (8)
and
ξ =
∫ tF
tA
P (µw(s)ds)
X(tF ; s)
w(tF )
. (9)
Γ is essentially the frequency of mutants at time tA, reflecting the first
step of our CI construction. If we set µ = 0, then ξ = 0 and solving (6) for
k¯ reduces to the two-point method if Γ is a fixed scalar. However when Γ
is small, mutation and the dynamics of k(t) during [tA, tF ] affect mutant
frequency at time tF in a significant way.
For the purposes of inference, we replace ξ in (6) by its expected value,
ξE . Taking expected values of a Poisson process, replaces P (µw(s)ds) by
µw(s)ds and then (3) and simple algebra give
ξE = µ
∫ tF
tA
ds exp[
∫ tF
s
ds′k(s′)], (10)
and the approximation
f(tF ) ≈ 1
1 + z
Γ+zξE
. (11)
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(11) is the two-point method generalization mentioned in step two, above.
In SIV infection, after time tA, m(t) is on the order of 1000s and
µw(t) is on the order of 100s. In this regime, mutations occur quickly
and averaging effects allow us to replace ξ by its expected value ξE with
small error. Importantly, in (11) only Γ depends on r(t) and then only
when t < tA; since r(t) is not well understood, especially near and after
peak viral load, basing inference only on r(t) dynamics prior to tA is a
significant, modeling advantage.
To define our CIs, we let P(µ, tA, PA, k¯) be the set of r(t), k(t), X(t; t0)
that we assume possible for early SIV dynamics and CTL response given
tA, PA, k¯. P(µ, tA, PA, k¯) is defined through a collection of constraints.
First, r(t), k(t), X(t; t0) ∈ P(µ, tA, PA, k¯) must satisfy the definitions and
assumptions already mentioned:
• k(t) has average k¯ over the interval [tA, tF ],
• r(t) satisfies (2),
• E[X(t; t0)] = w(t)/w(t0) for t0, t ∈ [0, tA].
We place two additional constraints on r(t) and k(t) motivated by our
desire to construct a lower-bound CI. The specific form of these constraints
is given subsection 3.2.2, where their technical motivation is made clear.
With P(µ, tA, PA, k¯) defined, we can consider functions mapping k¯ ∈ R
to values in P(µ, tA, PA, k¯), so that every k¯ is associated with a r(t), k(t), X(t; t0).
Letting p(k¯) be such a function; z, ξE and the distribution of Γ in (11)
can also be thought of as functions of k¯ which we write as zp(k¯), ξEp(k¯)
and Γp(k¯). In turn, using p(k¯) in (11) and plugging the result into (5)
leads to the definition
f˜CIp (k¯) = Binomial(
1
1 +
zp(k¯)
Γp(k¯)+zp(k¯)ξEp(k¯)
, n). (12)
We can form a CI by determining the interval of k¯ for which fˆ has a
p-value of greater than .05 under f˜CIp (k¯).
To orient the reader, we contrast the distributions f˜ and f˜CIp (k¯). f˜ is
binomially distributed with success probability f(tF ) and the distribution
of f(tF ) is parameterized by the given values of µ, tA, PA and specific
choices for r(t), k(t), X(t; t0). In contrast, f˜
CI
p (k¯) is binomially distributed,
but with success probability given by the approximation (11) of f(tF ); the
distribution of (11) is paramaterized by k¯, the given values of µ, tA, PA
and through p(k¯).
Let [emodel,1, emodel,2] and [elower,∞) be the model-based and lower-
bound CI, respectively. To form the model-based CI, we use precisely the
approach of the previous paragraph, defining a mapping pmodel(k¯) which
we decompose as,
pmodel(k¯) = (r
(k¯)
model(t), k
(k¯)
model(t), X
(k¯)
model(t)). (13)
The precise form of pmodel(k¯) is given below, in subsection 3.2.1. Then,
defining f˜CImodel by setting p = pmodel in (12),
emodel,1 = inf{k¯ : P (f˜CImodel(k¯) ≥ fˆ) ≥ .025)}, (14)
emodel,2 = sup{k¯ : P (f˜CImodel(k¯) ≤ fˆ) ≥ .025)}.
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To form the lower-bound CI, we do not build a function similar to
pmodel(k¯). Instead, we directly define ξE lower(k¯) and Γlower(k¯) which re-
place ξE and Γ in (12), thereby defining f˜
CI
lower(k¯). Below, in subsection
3.2.2, we specify ξE lower and Γlower. elower is defined by
elower = inf{k¯ : P (f˜CIlower(k¯) ≥ fˆ) ≥ .05)}. (15)
Importantly, ξE lower and Γlower guarantee the stochastic bound,
f˜CIp (k¯) ≤ f˜CIlower(k¯), (16)
for any mapping p from R to P(µ, tA, PA, k¯).
Now, still for fixed µ, tA, PA, let ractual(t), kactual(t), Xactual(t; t0) rep-
resent the values of r(t), k(t), X(t; t0) from which the data is sampled and
let k¯actual be the average of kactual(t) on [tA, tF ]. In the context of in-
ference, we do not know these actual parameters. Suppose that fˆ has a
p-value of greater than .05 given f˜CIactual, i.e. the f˜
CI generated by set-
ting Γ and ξE according to ractual(t), kactual(t) and Xactual(t; t0). For the
model based CI, assuming the actual parameters agree with the model
parameters defined by pmodel(k¯actual) gives
k¯actual ∈ [emodel,1, emodel,2]. (17)
For the lower-bound CI, by (16)
P (f˜CIlower(k¯actual) ≥ fˆ) ≥ P (f˜CIactual(k¯actual) ≥ fˆ) ≥ .05. (18)
Combining (15) and (18) gives
elower ≤ k¯actual, (19)
showing that our lower-bound CI contains kactual. Importantly, while
the model-based CI assumes that the actual parameters are given by
pmodel(k¯actual), the lower bound CI only assumes the actual parameters
are contained in P(µ, tA, PA, k¯actual).
3.2.1 Details for Model-Based CI
To define the model-based CI, we need to specify rmodel(t) for t < tA,
kmodel(t), and Xmodel(t; t0) for t < tA.
The expansion of viral load in both SIV and HIV infection has been
observed to be roughly exponential [34]. If we assume that the expansion
in the number of infected cells is also roughly exponential, then r(t) is
constant. Letting r0 be the constant growth rate, r0 must satisfy:
r0 =
1
tA
log(PA). (20)
For the model-based CI, we set
rmodel(t) = r0. (21)
The assumption that r(t) is constant should be viewed with caution
for several reasons. During the first days of infection, viral load is below
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measurable levels and may not be expanding at a constant rate. Further,
typically viral load is, at best, sampled every few days, meaning that in-
terpolated viral loads are prone to error. The ratio between viral load
and number of infected cells may change over time, for example due to
immune activation, making viral load dynamics an invalid proxy for in-
fected cell dynamics. Finally, typically viral loads are measured in the
blood and may differ from the viral loads in others compartments.
The dynamics of CTL kill rates in early SIV and HIV infection are not
completely understood. However, tetramer labeling and IFN-g ELISPOT
assays tracking response are available, e.g [35, 7, 36]. For either mea-
surement approach, a typical response is an initial spike in CTL response
lasting several days followed by either a steep or gradual decline. We
can use this profile to construct a generic kmodel(t). For a given k¯, we
set k(tA) = 0, k(tA + 4) = 2k¯, and k(tF ) = 0; t values falling inside
(tA, tA + 7) and (tA + 7, tF ) are linearly interpolated. Notice, kmodel(t)
has the required average, k¯. Alternatively, kmodel(t) can be specifically
constructed to match tetramer data, the case for the Vanderford et. al.
dataset.
We set Xmodel(t; t0) = w(t)/w(t0), so that Xmodel(t; t0) is simply the
expected value of X(t; t0).
3.2.2 Details for Lower-Bound CI
To construct the lower bound CI, we construct upper bounds for Γ and
ξE ; we label these upper bounds Γlower and ξE lower since they are used to
form the lower-bound CI. If we replace Γ and ξE by upper bounds in (11),
standard calculus arguments show the resulting expression is an upper
bound of f(tF ), leading to (16).
From (4) we have,
Γ =
∫ tA
0
dP (µw(s)ds)
1
w(tA)
X(tA; s). (22)
Our first step in constructing Γlower is to remove dependence on X(tA; s).
In the appendix, section A.2, we prove the following stochastic bound
which applies to any random variable with values in {0, 1, 2, . . . , },
X(tA; s) ≤ E[X(tA; s)]
U
, (23)
where U is a uniform random variable on [0, 1]. Plugging this bound into
(22) and recalling E[X(tA; s)] = w(tA)/w(s) for t < tA gives
Γ ≤
∫ tA
0
dP (µw(s)ds)
1
w(s)
(
1
U
)
. (24)
Note that every time the Poisson process jumps, an independent sample
of U must be drawn.
The integral in (24) is easier to work with when the Poisson process has
a constant rate. This can be achieved by defining W(t) =
∫ t
0
dsw(s) and
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applying the substitution q = W(s). Further substitutions and analysis,
detailed in appendix section A.1, lead to
Γ =
∫ W(tA)
0
P (µdq)
(
1
1 + r0q
)
G(s(q))
(
1
U
)
, (25)
where s(q) = W−1(q), r0 is defined in (20), and G(t) can be characterized
through the jump times of a Poisson process as follows. Starting at time
t, run a Poisson process with rate r(t) backwards in time from t to 0. Let
T represent the duration of time before the first jump, but if there are no
jumps before time 0, set T = t. For example, if the jump occurs at time
t− c then we have run the process c time units before the jump occurred,
making T = c. This example assumes that c < t. Then,
G(t) =
1
w(t)
+ r0E[T ]. (26)
From (26) we have the immediate bound, G(t) ≤ 1 + r0t, which is
optimal because setting r(t) = 0 on [, tA] gives G(t) ≈ 1 + r0t for any
t ∈ [, tA]. However, such an r(t) is not realistic for SIV. To deal with
such cases, and lead to an improved bound on G(t), we introduce rmin(t)
defined by linearly interpolating between the four points rmin(0) = 0,
rmin(tA/3) = 3r0/4, rmin(2tA/3) = 3r0/4 and r(tA) = 0. The form of
rmin(t) is somewhat arbitrary. Intuitively, we suppose that growth rates
may be low at initial infection or near peak viral load, so at the endpoints
we choose rmin(t) = 0 and in between we assume growth rates are at least
3/4th of the average growth rate, r0. As we lower this fraction, say from
3/4 to 1/2, the bound of G(t) becomes poorer.
We require r(t) ≥ rmin(t) for r(t) to be in P(µ, tA, PA, k¯). Given this
constraint, we can use rmin(t) as a worst case and derive the bound,
Γ ≤
∫ W(tA)
0
P (µdq)
(
1
1 + r0q
)
Gmax(s(q))
(
1
U
)
, (27)
where Gmax(t) is constructed using rmin(t) to define T and the w(t) in
(26) is replaced by wmin(t), where wmin(t) =
∫ t
0
dsrmin(s).
The right hand side of (27) is almost independent of r(t), except for the
boundary point of integration, W(tA). Recall that w(tA) = PA and W(tA)
is the integral of w(t) from time 0 to tA. Intuitively, the faster the wild-
type population expands, the more mutations will occur; W(tA) quantifies
this intuition. Generally, the best bound of W(tA) is W(tA) ≤ PAtA which
is achieved if the viral population instantly reaches size PA and then stays
fixed. Clearly this is not biologically realistic, so we introduce wmax(t)
defined by the growth rate rmax(t),
rmax(t) = 2k¯(tA − t), (28)
and require that r(t) ∈ P(µ, tA, PA, k¯) satisfy w(t) ≤ wmax(t) for t ≤ tA
(recall that w(t) for t < tA is parameterized by r(t) through (1)). Letting
Wmax(tA) be the integral of wmax(t), we can finally define,
Γlower =
∫ Wmax(tA)
0
P (µdq)
(
1
1 + r0q
)
Gmax(s(q))
(
1
U
)
, (29)
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which satisfies the stochastic bound, Γ ≤ Γlower.
To form an an upper bound for ξE , we construct a klower(t) that max-
imizes ξE for fixed k¯. With solely the restriction k(t) ≥ 0, no such maxi-
mum exists. For example, letting
k(t) =
{
0 for t < tF − 
2k¯

(tF − t) for t ≥ tF − , (30)
then ξE →∞ as → 0 with k¯ remaining fixed.
To avoid such pathological cases, we assume k(t) is formed through
two piece-wise linear interpolations. More precisely, we allow k(t) to take
any non-negative values at times tA, t
∗, tF where t∗ is any time in [tA, tF ].
For other times t ∈ [tA, tF ], k(t) is formed by linearly interpolating based
on k(tA), k(t
∗), and k(tF ). Since tF − tA is less than 2 weeks for the
datasets we consider, this parametrization of k(t) allows for the range of
kill rate profiles seen in experimental datasets. We could define k(t) by
linearly interpolating more than three points; but as the number of such
points rises, our bound of ξE will become poorer.
With k¯ fixed, set
klower(t) = 2k¯
(
t− tA
tF − tA
)
(31)
Let ξE lower(k¯) be the value of ξE based on klower(t), and let ξE(k¯) corre-
spond to any k(t) satisfying our two piece linear interpolation assumption
and having average k¯. Then standard optimization arguments show,
ξE(k¯) ≤ ξE lower(k¯). (32)
Intuitively, klower(t) is a CTL response that expands slowly and such re-
sponse allows more wild types to mutate during [tA, tF ] leading to a higher
fraction of mutants at tF .
In the preceding paragraphs we’ve specified two additional constraints
on P(µ, tA, PA, k¯) beyond those already mentioned:
• r(t) ∈ P(µ, tA, PA, k¯) if for all t ≤ tA: w(t) ≤ wmax(t) and r(t) ≥
rmin(t),
• k(t) ∈ P(µ, tA, PA, k¯) if k(t) can be constructed through the linear
interpolation of the three points k(tA), k(t
∗), and k(tF ) with t∗ ∈
[tA, tF ].
Figure 4, which is constructed assuming tA = 14 and PA = 10
8, gives
an intuition for the constraints on r(t). Roughly, r(t) ∈ P(µ, tA, PA, k¯)
if the w(t) it parametrizes falls between wmax(t) and wmin(t). This is
not quite right, because actually we require r(t) ≥ rmin(t) rather than
w(t) ≥ wmin(t), but the figure gives an intuition for the range of acceptable
r(t). Seven days into infection, wmax and wmin have log10 values of 6 and
2, showing that there is substantial variation in acceptable r(t). Notice
that rmodel(t) is roughly a middle ground.
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Figure 4: Constraints on r(t) and w(t)
3.2.3 Dataset Parameters
For both Bimber et. al and Vanderford et. al. datasets, we set n in (5) to
100. If each sequence samples from the viral population independently, n
represents the number of sequences sampled. Since both datasets are gen-
erated through deep sequencing, their sequence counts are in the 1000s;
however, pyrosequencing is subject to biasing, so that the effective sam-
pling count is likely much lower. We set n = 100, reflecting a conservative
assumption of frequency estimation with roughly 10% accuracy.
rmodel(t) and Xmodel(t; t0) have the generic form specified in section
3.2.1 for both datasets. For Bimber et. al., kmodel(t) also takes the generic
form mentioned in that section: the linear interpolation of k(tA) = 0,
k(tA + 4) = 2k¯, and k(tF ) = 0. For Vanderford et. al., the kmodel(t)
used in the LN compartment is the linear interpolation of k(tA) = 0 and
k(tF ) = 2k¯, while the kmodel in the RB compartment takes the generic
form used in Bimber et. al.
Values for µ, tA, PA and tF are given in the Results section.
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3.2.4 Fitness Costs
To model fitness costs, we change the expected value of X(t; t0) from (3)
to
E[X(t; t0)] = exp[
∫ t
t0
ds(r(s)− cfit)] (33)
= exp[−cfit(t− t0)]
(
w(t)
w(t0)
)
exp[
∫ t
t0
dsk(s)],
where cfit is the fitness cost associated with mutation. Changing X(t; t0)
alters the dynamics of m(t), although (4) still holds.
For a moment, assume that we are given cfit and would like to estimate
k¯. We can apply (11) as before, but with Γ, z and ξE replaced by corre-
sponding versions defined under the fitness cost model: Γfit, zfit, and ξEfit.
Assuming that mutants are less fit gives the stochastic bound Γfit ≤ Γ,
while zfit and ξEfit equal z, ξE under the transformation k(t)→ k(t)−cfit.
More precisely,
zfit = exp[−(k¯ − cfit)(tF − tA)], (34)
and
ξEfit = µ
∫ tF
tA
ds exp[
∫ tF
s
ds′(k(s′)− cfit)]. (35)
Let [efitmodel,1, e
fit
model,2] and [e
fit
lower,∞) be the model-based and lower-
bound CIs constructed under the fitness model with cfit given. Using the
same arguments and notation stated in the paragraph below (16) gives
k¯actual ∈ [efitmodel,1, efitmodel,2] (36)
if the model parameters and actual parameters are equal, and
k¯actual ∈ [efitlower,∞) (37)
if the actual parameters are in P(µ, tA, PA).
Now suppose that we construct our CIs under the model assuming
equal fitness, but that fˆ is drawn from f(tF ) under the fitness cost model.
(Recall that the model-based and lower-bound CIs under the equal fitness
model are [emodel,1, emodel,2] and [elower,∞), respectively.) The stochastic
bound, Γfit ≤ Γ gives
1
1 + zfit
Γfit+zfitξE fit
≤ 1
1 + z
Γ+zξE
, (38)
where zfit and ξEfit are formed with kill rate k(t) while z and ξE are
formed with kill rate k(t) − cfit. The expression to the left and right
sides of the ≤ in (38) are used to form CIs under the fitness cost and
equal fitness models, respectively. Exploiting (38) as we did (16), gives :
emodel,1 + cfit ≤ efitmodel,1, emodel,2 + cfit ≤ efitmodel,2 and elower + cfit ≤ efitlower.
By combining (36) and (37) with the relations directly above, we find
k¯actual − cfit ≥ emodel,1, (39)
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assuming the actual parameters and model parameters are equal, and
k¯actual − c ∈ [elower,∞) (40)
assuming the actual parameters are in P(µ, tA, PA).
When fitness costs are included, the escape rate is given by the differ-
ence between the average kill rate and the mutation fitness cost [3]. From
(40), the lower-bound CI always includes the escape rate, even though
the CI is formed under a model assuming equal fitness. From (39), the
model-based CI may not contain the escape rate, but the escape rate is
always above the left endpoint of the CI.
3.3 Numerical Experiments
Through simulation, we investigated the accuracy of estimating f(tF ), the
mutant frequency at sampling time, through (11). Figure 5 considers a
setting similar to the lymph node compartment of the Vanderford et. al.
dataset, with relatively early CTL response and sampling times: tA = 9
and tF = 14. For subfigures A and B we imagined peak viral loads at
day 14 with 106 and 107 infected cells, and based on these values we
interpolated the number of infected cells at tA by assuming a constant
growth rate; this gave PA values of roughly 7200 and 32000, respectively.
The subfigures show empirical cdfs constructed from 105 simulations, the
exact cdf is generated by simulating the model while the approximate cdf
uses (11). The growth and kill rates were those used to construct the
model-based CI for the Vanderford et. al. dataset, with k¯ set at 1.
The approximating cdfs in both subfigures are relatively accurate,
although the larger PA in subfigure B improves the accuracy. With
PA = 32000 the mutation rate at time tA, given by µPA, is roughly
9. Generally, across different numerical experiments (data not shown), we
found that a mutation rate at time tA greater than 5 led to an accurate
approximation of f(tF ) by (11). Mutation rates at tA are on the order of
104 for our Bimber et. al. parametrization.
To assess the sensitivity of our CIs to the parameters µ, tA, PA; the
growth and kill rates, r(t), k(t); and the offspring distribution X(tA; t);
we used the following testing approach.
1. We generated simulated mutation frequencies at day tF using our
model and a choice for the parameters. We refer to these parameters
as the simulation parameters.
2. Given the simulated mutation frequencies at day tF , we chose pa-
rameter values and built the model-based and lower-bound CIs. We
refer to these parameters as the inference parameters.
Figure 6 shows results with tF = 21. Each tic in each subfigure was
generated by repeating the two step, testing approach 1000 times and
averaging.
For all subfigures, our inference parameters were fixed at µ = 3∗10−4,
tA = 14, PA = 10
8 and r(t) = rmodel(t), k(t) = kmodel(t), X(tA; t) =
wmodel(tA)/wmodel(t). Intuitively, given data we always guessed the same
parameters; but, importantly, to generate the lower-bound CI only the
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Figure 5: Accuracy of (11). The subfigures show cdfs for f(tF ) based on exact
simulations and the approximation (11). For both subfigures, tA = 9 and tF =
14, but in (A) PA = 7200 and (B) PA = 32000.
values of µ, tA, PA are needed. For the simulation parameters, in all sub-
figures we fixed µ, tA, PA to the same values as the inference parame-
ters, except that in each subfigure the x-axis shows how we varied a sin-
gle one of these parameters. For example, in subfigure A we simulated
the data using µ = 3 ∗ 10−4, tA = 14, and with PA taking on the val-
ues 106, 108, 1010 over three separate numerical experiments. For figures
A,B,C we set r(t), k(t), X(tA; t) to the same values as the inference param-
eters, while for figures D,E,F the values were different (see the Appendix
section A.3 for the specific values we chose); so what distinguishes subfig-
ure A from D is whether or not the inference and simulation parameter
values for k(t), r(t), X(tA; t) are equal and similarly for subfigures B,E and
C,F.
In all experiments we set k¯ = .8 (the k(t) chosen as both simulation and
inference parameters depend on k¯). In subfigures A,B,C the tics PA = 10
8,
tA = 14 and µ = 3 ∗ 10−4, respectively, are the same experiment in which
simulation and inference parameters are equal. For this case, the model
based-CI contains the true k¯ value. Subfigure A shows that varying PA
has little effect on our model-based CI, while the other subfigures show
that varying any other parameter leads to an erroneous CI. This, however,
is not the case for the lower-based CI which contains the true k¯ over all
parameter choices.
Figure 6 shows averaged CI. Of the 1000 experiments run to produce
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Figure 6: Results of numerical experiments. In each subfigure, one parameter
was varied. Subfigures A,B,C show experiments in which the CI is inferred with
the same r(t), k(t), X(t; t0) values as used for generating simulated mutation
frequencies, in subfigures D,E,F the r(t), k(t), X(t; t0) differ between inference
and simulation. See text for further details.
each tic, the model-based CI contained k¯ approximately 92% of the time
when the simulation and inference parameters were identical or only PA
was varied as in subfigure A. For all other tics, the model-based CI con-
tains k¯ less than 25% of the time. In contrast, over all tics and all 1000
experiments for each tic, the lower-bound CI always contained k¯.
We also ran experiments in which no simulated and inference parame-
ters agreed. The inference parameters were unchanged from the previous
experiments, but the simulated parameters were set at the values for which
the lower bound was highest in Figure 6 (µ = 3∗10−3, PA = 1010, tA = 16,
and r(t), k(t), X(t; t0) that of subfigures D,E,F in Figure 6). Over 1000
experiments, no model-based CI contained k¯, while the lower-bound CI
always contained k¯.
As can be seen from Figure 6, the lower-bound CI significantly un-
derestimates k¯ (recall we set k¯ = .8 for the numerical experiments).
Some of this underestimate comes from model uncertainty. In forming the
lower-bound CI, we constructed ξE lower and Γlower as upper bounds for
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ξE and Γ. ξE lower is an optimal bound because klower(t) ∈ P(µ, tA, PA, k¯),
so when k(t) = klower(t) we have ξE = ξE lower. In situations when
ξE lower > ξE , the lower-bound CI will underestimate k¯ as a consequence
of our uncertainty regarding which k(t) ∈ P(µ, tA, PA, k¯) generated the
data. But the situation is different for Γlower because no r(t) can simul-
taneously satisfy r(t) = rmax(t) and r(t) = rmin(t) and no X(t; t0) can
satisfy X(t; t0) = E[X(t; t0)]/U . When we simulate data using pmodel
(meaning we use rmodel(t), kmodel(t), X(t; t0) = E[X(t; t0)]) and take
kmodel(t) = klower(t), we find that approximately 90% of the distance be-
tween the lower bound and the correct confidence interval comes from
bounding X(t; t0) by E[X(t; t0)]/U while 10% comes from the use of rmin
and rmax. This is the case, for example, for the second tic of Figure 6A,
in which the lower bound is .21 and the correct CI is [.66, .94].
4 Discussion
Inferring the rate of the first CTL escape involves a tradeoff. One one
hand, the existing two-point method is largely model independent but
can only be applied using two sampled timepoints, meaning that the early
part of the escape is often missed and inference implicitly focuses on later
parts of the escape. On the other hand, if a more parameterized method is
used, the early part of the escape can be considered but inference results
depend on model structure and the parameter values chosen.
In this work, we have developed escape rate inference methods ap-
plicable to single timepoint datasets with an effort to minimize model
dependence and the number of parameters. To do this, we construct
lower-bound confidence intervals which account for model uncertainty, al-
though three parameters must still be specified.
As our results show, in some cases these lower-bounds are not infor-
mative, but in many cases the lower-bounds allow us to understand CTL
escape in a more dynamic fashion. In the Bimber et. al. dataset, lower-
bound CIs combined with the two-point method reveal faster rates for the
first CTL escape during days 14-21 than days 21-28. The Vanderford et.
al. data has a similar pattern, with faster rates of escape in the lymph
nodes during days 9-14 than during days 14-28. Further, we were able to
show that escape in the rectal mucosa is at least as fast, and likely faster,
than lymph node escape during days 14-28.
The lower-bound CI accounts for uncertainty in the population dy-
namics of SIV infected cells and CTL response, however our methods still
depend on the parameters µ, tA and PA. We made the choice µ = 3∗10−4,
as mentioned in [24] the mutation rate of TAT-SL8 is possibly lower but
unlikely to be higher. A lower value for µ would raise our escape rate CIs,
leaving our conclusions unchanged. We chose tA, the time CTL response
begins, based on tetramer data for the percentage of CD8+ lymphocytes
recognizing the epitope. To the extent such data reflects underlying CTL
kill rates, our choice of tA is justified. Finally, numerical experiments
show the CIs are weakly dependent on PA, the number of infected cells
at time tA.
Our estimates are in line with previous work. Mandl et. al. [24] con-
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sidered escape at TAT-SL8 in rhesus macaques using a standard-model
based inference method. By fitting the standard-model using six time-
points, they estimated escape rates in the range of .3 to .9. We applied our
methods to their dataset, see Figure 7, finding lower bound CIs consistent
with the estimates of Mandl et. al. Further, in two of the three animals,
lower-bound CI for the escape rate during days 14-20 were greater than
the two-point method CI for the days 20-27 escape rate. The exception,
animal RVy5, had a weaker TAT-SL8+, CTL response prior to day 20
than the other two animals. As in Bimber et. al., an association seems to
exist between the strength of CTL response and early escape rates. How-
ever, these associations are not statistically significant and more work is
required.
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Figure 7: Escape Rates for Mandl et. al.
In this work, we have not distinguished between different types of
epitope mutations, although CTL escape typically involves multiple mu-
tation variants [9]. As CTL binding affinity may differ between mutation
variants, we are really inferring an average escape rate over all mutations
at the epitope. For TAT-SL8, most mutations arising in escape have low
binding affinity, so our estimates may apply without much modification
[1, 30].
As discussed in the Methods section, the lower-bound CI contains the
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escape rate even when mutations incur a fitness cost. Reversion studies
suggest TAT-SL8 mutations may not be associated with a fitness cost,
but mutations at other epitopes are often less fit [16, 13].
The lower-bound CI as currently constructed is overly conservative.
Often, as demonstrated by numerical experiments in the Methods sec-
tion, the lower-bound CI significantly underestimates the escape rate even
when model uncertainty is accounted for. Improving the lower-bound CI
requires better quantitative understanding of acute infection. For exam-
ple, the number of offspring infected cells descendant from a single HIV
or SIV infected cell is not well understood. Estimates of R0 provide av-
erages, but better lower-bounds require knowledge of the distribution.
Since we lack such estimates we are forced to use a crude bound, i.e.
X(t; t0) ≤ E[X(t; t0)]/U , leading to overly conservative lower-bound CIs.
Future work leading to improved lower-bound CIs would greatly expand
the range of datasets we could consider as well as sharpen our current
estimates.
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A Appendix
A.1 Derivation of (25) and (26)
To see (25) and (26), first apply the substitution q = W(s) to the integral
in (24), giving
Γ =
∫ W(tA)
0
P (µdq)
1
w(s(q))
(
1
U
)
. (A.1)
When r(t) = r0, a simple computation shows w(s(q)) = 1+r0q. To under-
stand deviations from constant r(t) we rewrite (A.1) using the expression
1 + r0q,
m(tA)
w(tA)
=
∫ W(tA)
0
P (µdq)
1
1 + r0q
[G(s(q))]
(
1
U
)
, (A.2)
where G(s(q)) = (1 + r0q)/w(s(q)) but can be profitably expressed as
G(t) =
1
w(t)
+ r0
∫ t
0
ds exp[−
∫ t
s
ds′r(s′)]. (A.3)
(A.3) can be seen by noting
q(t)/w(t) = W(t)/w(t) =
∫ t
0
dsw(s)/w(t), (A.4)
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and then replacing w(s) by exp[
∫ s
0
ds′r(s′)] and similarly for w(t).
Applying integration by parts to the integral in (A.3) we have,
G(t) =
1
w(t)
+ r0
[
−
∫ t
0
ds(s)r(s) exp[−
∫ t
s
ds′r(s′)] + s exp[−
∫ t
s
ds′r(s′)]
∣∣∣∣t
0
]
]
(A.5)
=
1
w(t)
+ r0
[
−
∫ t
0
ds(t− (t− s))r(s) exp[−
∫ t
s
ds′r(s′)] + t
]
=
1
w(t)
+ r0
[
−t(1− 1
w(t)
) +
∫ t
0
ds(t− s)r(s) exp[−
∫ t
s
ds′r(s′)] + t
]
=
1
w(t)
+
1
w(t)
r0t+
∫ t
0
ds(t− s)r(s) exp[−
∫ t
s
ds′r(s′)].
In the last expression, r(s) exp[− ∫ t
s
ds′r(s′)] can be seen as the non-
normalized pdf for the jump time of a Poisson process run at rate r(t) from
t backwards in time. Now the integral of the pdf,
∫ t
0
dsr(s) exp[− ∫ t
s
ds′r(s′)]],
evaluates to 1− 1/w(t). We can then write,
G(t) =
1
w(t)
+r0
(
t
w(t)
+ (1− 1
w(t)
)
∫ t
0
ds(t− s)r(s) exp[−
∫ t
s
ds′r(s′)]
1− 1
w(t)
)
(A.6)
which is exactly the statement (26).
A.2 Proof of (23)
For the sake of generality we consider a random variable Y with the re-
striction that Y ∈ {0, 1, 2, . . . }. Throughout, we use y to represent a
scalar and Y to be the random variable. First, letting F (y) be the cdf of
Y , we show that for y ≥ 1,
y ≤ E[Y ]
1− F (y − 1) . (A.7)
Indeed, this is just a Chebyshev bound.
y(1− F (y − 1)) = yP (Y ≥ y) ≤ E[Y ]. (A.8)
Next we define a r.v. H by,
H =
{
1− F (Y − 1) if Y 6= 0
1 otherwise.
(A.9)
Then using (A.7) and the definition of H gives,
Y ≤ E[Y ]
H
(A.10)
We’re done if we can show that H ≥ U where U is a uniform r.v. on [0, 1].
To see this, set P (Y = i) = ci. Then,
H =
{ 1 with probability c01− c0 with probability c1
1− c0 − c1 with probability c2
...
(A.11)
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To prove H ≥ U , define the mapping Φ : [0, 1]→ {1, 1−c0, 1−c0−c1, . . . },
Φ(x) =
{ 1 for x ∈ [1− c0, 1]1− c0 for x ∈ [1− c0 − c1, 1− c0]
1− c0 − c1 for x ∈ [1− c0 − c1 − c2, 1− c0 − c1]
...
(A.12)
Then U ≤ Φ(U) ∼ H and we are done.
A.3 Details for Numerical Experiments
Here are the values for r(t), k(t), X(t; t0) used as simulation parameters
to generate subfigures D,E,F in Figure 6.
r(t) =
{ .2r0 if t ∈ [0, tA3 )
1.8r0 if t ∈ [ tA3 , 2tA3 )
r0 if t ∈ [ 2tA3 , tA]
(A.13)
k(t) is linearly interpolated from the following three points: k(tA) = 0,
k(tA + 4) = k˜, k(tF ) = k˜ where
k˜ = k¯
(
tF − tA
tF − tA − 4
)
, (A.14)
and X(t; t0) is given by
X(t; t0) = 100
(
w(t)
w(t0)
)
Binomial(.01; 1). (A.15)
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